Thrivent Financial for Lutherans lifted its stake in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 15.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 340,297 shares of the company’s stock after purchasing an additional 46,673 shares during the quarter. Thrivent Financial for Lutherans’ holdings in HealthEquity were worth $32,652,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. KBC Group NV raised its stake in HealthEquity by 16.1% in the 3rd quarter. KBC Group NV now owns 2,463 shares of the company’s stock worth $202,000 after acquiring an additional 341 shares during the last quarter. Swiss National Bank raised its stake in shares of HealthEquity by 0.4% in the third quarter. Swiss National Bank now owns 169,900 shares of the company’s stock worth $13,906,000 after purchasing an additional 600 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of HealthEquity by 28.6% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 109,162 shares of the company’s stock worth $8,935,000 after purchasing an additional 24,266 shares during the period. King Luther Capital Management Corp boosted its position in HealthEquity by 1.2% in the third quarter. King Luther Capital Management Corp now owns 45,847 shares of the company’s stock valued at $3,753,000 after buying an additional 552 shares during the last quarter. Finally, Intech Investment Management LLC increased its holdings in HealthEquity by 59.5% in the 3rd quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock worth $1,724,000 after buying an additional 7,859 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages have commented on HQY. Raymond James lifted their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Tuesday, February 25th. JMP Securities boosted their target price on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, March 14th. Royal Bank of Canada lifted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $112.92.
Insider Buying and Selling
In related news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 2.20% of the stock is owned by insiders.
HealthEquity Stock Up 0.3 %
HealthEquity stock opened at $84.60 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock has a market capitalization of $7.33 billion, a PE ratio of 77.61, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The business has a 50 day simple moving average of $105.20 and a 200-day simple moving average of $95.51. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $115.59.
HealthEquity Company Profile
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Stories
- Five stocks we like better than HealthEquity
- How to Read Stock Charts for Beginners
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Using the MarketBeat Dividend Yield Calculator
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.